Current Report Filing (8-k)
28 Februar 2022 - 9:05PM
Edgar (US Regulatory)
0000350737
false
OCEAN BIO CHEM INC
0000350737
2022-02-28
2022-02-28
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
February
28, 2022
OCEAN
BIO-CHEM, INC.
(Exact
name of registrant as specified in charter)
Florida |
|
0-11102 |
|
59-1564329 |
(State
or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(I.R.S.
Employer
Identification No.) |
4041
S.W. 47 Avenue, Fort Lauderdale, Florida |
|
33314 |
(Address of principal executive
offices) |
|
(Zip Code) |
(954)
587-6280
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|
|
|
Common Stock, $0.01 par value |
|
OBCI |
|
The NASDAQ Stock Market |
Item
8.01 Other Events.
On
February 24, 2022, Ocean Bio-Chem, Inc. (the “Company”) the Board of Directors voted and approved the quarterly regular dividend
increase to $0.04 per/share.
The
information furnished pursuant to Item 8.01 of this Current Report, including the exhibits furnished herewith, shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section,
nor shall it be incorporated by reference into future filings by the Company under the Securities Act of 1933, as amended, or under the
Securities Exchange Act of 1934, as amended, unless the Company expressly sets forth in such future filing that such information is to
be considered “filed” or incorporated by reference therein.
Item 9.01
Financial Exhibits and Other Events
The
Company is furnishing the following exhibit to this Current Report:
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
OCEAN BIO-CHEM, INC. |
|
|
|
Date: February 28, 2022 |
By: |
/s/ Jeffrey S. Barocas |
|
|
Jeffrey S. Barocas |
|
|
Chief Financial Officer |
2
Ocean Bio Chem (NASDAQ:OBCI)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Ocean Bio Chem (NASDAQ:OBCI)
Historical Stock Chart
Von Mai 2023 bis Mai 2024
Echtzeit-Nachrichten über Ocean Bio Chem Inc (NASDAQ): 0 Nachrichtenartikel
Weitere Ocean Bio Chem Inc News-Artikel